Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia

This publication has 31 references indexed in Scilit:

• Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia
  Journal of Lipid Research, 2010
• Antisense Oligonucleotide Directed to Human Apolipoprotein B-100 Reduces Lipoprotein(a) Levels and Oxidized Phospholipids on Human Apolipoprotein B-100 Particles in Lipoprotein(a) Transgenic Mice
  Circulation, 2008
• Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia
  Nature Clinical Practice Cardiovascular Medicine, 2008
• Niacin and Lipoprotein(a): Facts, Uncertainties, and Clinical Considerations
  The American Journal of Cardiology, 2008
• New targets and emerging therapies for reducing LDL cholesterol
  Current Opinion in Lipidology, 2007
• Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations
  The American Journal of Cardiology, 2005
• Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatin
  American Heart Journal, 2004
• Approaches for the sequence-specific knockdown of mRNA
  Nature Biotechnology, 2003
• A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia
  Atherosclerosis, 2003
• N‐acetylcysteine and serum concentrations of lipoprotein(a)
  Journal of Internal Medicine, 1991